Hypercortisolism Impact on Hypertension and Hyperglycemia and Beyond
Ralph A. DeFronzo • 2024 • Heart in Diabetes 2024
Posted with permission of the presenter.
© 2024 Corcept Therapeutics, Incorporated
About jeremiah@devisedesigns.com
This author has not written his bio yet.
But we are proud to say that jeremiah@devisedesigns.com contributed 143 entries already.
Entries by jeremiah@devisedesigns.com
Difficult-to-Control Diabetes: Is Cortisol at Play?
• 2023 • Roundtable Discussion
Miricorilant Reduced Liver Fat and Cardiometabolic Disease Markers in a Phase 1b, Open-Label Dose-Finding Study in Patients with Non-Alcoholic Steatohepatitis (NASH)
Alkhouri et al. • 2024 • NASH-TAG 2024 Congress
Miricorilant reduced liver fat and cardiometabolic disease markers in a phase 1b, open-label dose-finding study in patients with non-alcoholic steatohepatitis (NASH)
Alkhouri et al. • 2023 • AASLD 2023 Congress
ROSELLA (GOG-3073, ENGOT-OV72/MITO): A Phase 3 Study of Relacorilant + Nab‑paclitaxel vs. Nab‑paclitaxel in Platinum-Resistant Ovarian Cancer
Lorusso et al. • 2023 • IGCS 2023 Congress